Cannabis for Obesity Trial
ConditionObesity
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-65
SponsorJoshua A. Lile, Ph.D.
About this trial
The goal of this study is to determine the initial efficacy of once daily oral cannabis for weight loss in obese individuals.
Eligibility criteria
Qualifiers
Male or female.
Age 18-65 years.
BMI >=30 kg/m2 (i.e., obese).
In good health, determined by no clinically significant findings from medical history, physical examination, 12-lead ECG, vital sign measurements, and clinical laboratory evaluations at Screening and/or Check-in as assessed by one of the MD study personnel.
Disqualifiers
UK Students cannot participant
Current cannabis use (e.g., past month; negative test for cannabinoids during screening) and no more than 15 self-reported lifetime uses.
Self-reported current use of CBD.
Severe past negative experience with cannabis or cannabinoid use (e.g., panic attack, anxiety).
Trial design
Treatments tested in this trial
- Cannabis
- Placebo
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Joshua A. Lile, Ph.D.
Lead sponsor
University of Kentucky
Sponsor institution
Source ClinicalTrials.gov